Archived
How_to_Conduct_Non-Federal_Stem_Cell_Research_Without_Violating_the_Federal_Stem_Cell_Funding_Prohibition
The article by Robert J. Kenney Jr. provides comprehensive guidance for federally funded research institutions seeking to conduct human embryonic stem cell (hESC) research that is prohibited from federal funding under the Bush administration’s policy. The policy, announced in August 2001, restricts the use of federal funds to a narrow set of pre-approved hESC lines, necessitating stringent safegua
Approaches_to_Developing_an_Institutional_Conflict_of_Interest_Policy_-_Section_Six
Section Six of the COGR document "Approaches to Developing an Institutional Conflict of Interest Policy" provides a curated resource bibliography and comprehensive list of links to institutional and federal policies relevant to the development of conflict of interest (COI) policies at universities and research organizations. The primary focus is on institutional financial conflicts of in
COGR Testimony at NIH Hearings on March-in Rights
NIH has denied the request from Essential Inventions, Inc. to exercise march-in rights under The Bayh-Dole Act in connection with the pricing of Norvir, marketed by Abbott Laboratories for the treatment of patients with HIV/AIDS. The decision and related materials are available online.
